Psoriasiform dermatitis following intravenous immunoglobulin therapy: A case series.

Autor: Willenbrink TJ; Department of Dermatology and Dermatologic Surgery, University of Texas at Austin Dell Medical School, Austin, TX, USA., Robinson IS; Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina, Charleston, SC, USA., Connett JS; Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina, Charleston, SC, USA., Wine Lee L; Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina, Charleston, SC, USA.; Department of Pediatrics, Medical University of South Carolina, Charleston, SC, USA.
Jazyk: angličtina
Zdroj: Pediatric dermatology [Pediatr Dermatol] 2021 Nov; Vol. 38 (6), pp. 1529-1531. Date of Electronic Publication: 2021 Oct 29.
DOI: 10.1111/pde.14835
Abstrakt: Intravenous immunoglobulin (IVIg) is a frequently used treatment modality in the pediatric inpatient population for acute diseases such as Kawasaki disease and Stevens-Johnson syndrome. There are few reported cutaneous adverse events after IVIg in the pediatric population. Here, we present two patients with psoriasiform dermatitis appearing after IVIg treatment for two different disease processes, Kawasaki disease and mycoplasma-associated mucositis, suggesting an association with the treatment instead of the disease process.
(© 2021 Wiley Periodicals LLC.)
Databáze: MEDLINE
Externí odkaz: